Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
NÖ Do?an et al. 2015 Turkey | 74 adults presenting to a single centre Emergency Department over a one-year period with CO intoxication Venous lactate measured. | Retrospective cross-sectional study | Venous Lactate (mmol/L) | Treated with normobaric oxygen therapy 1.0 (0.9-1.7) vs HBO 2.3 (1.7-3.1), p<0.001 | Relatively small sample size. Single centre and retrospective study. Small number of patients with elevated lactate. |
Area under ROC curve (AUC) for accuracy predicting HBO treatment for plasma lactate concentration | 0.838 (95% CI 0.743-0.933) | ||||
Predicting need for HBO treatment Venous lactate of 1mmol/lL: Negative predictive value | 96.3% | ||||
Predicting need for HBO treatment: Venous lactate of 1.85 mmol/L Sensitivity | 70.8% | ||||
Predicting need for HBO treatment: Venous lactate of 1.85 mmol/L Specificity | 78% | ||||
Predicting need for HBO treatment : Altered mental status | More common in lactate >2.1 mmol/L (73.7% vs. 10.9%, p<0.001) | ||||
Cervellin G et al. 2014 Italy | 38 adult patients with CO poisoning admitted (median age 37) to a single centre Emergency Department between 2012 and 2013. Arterial lactate measured. | Retrospective review | Predictor of hospital admission | No admission, lactate 1.2 (IQ 1.0-1.6) vs. admission 1.8 (IQ 1.4-2.0) (p<0.001) | Retrospective study, with little discussion of the study limitations. Limited generalisability due to small sample size and single centre study. |
Lactate AUC for predicting hospital admission | 0.85 (95% CI, 0.72–0.97; p<0.001) | ||||
Predictor of need for HBO treatment | No HBO, lactate 1.1 (IQ 1.0-1.6) vs. HBO treatment 1.5 (IQ 1.3-1.9) (p=0.003) | ||||
Lactate AUC for predicting HBO treatment | 0.54 (95% CI, 0.31–0.78; p=0.366) | ||||
Lactate >1.2mmol/L for predicting need for hospital admission: Sensitivity | 1.00 | ||||
Lactate >1.2mmol/L for predicting need for hospital admission: Specificity | 0.57 | ||||
Moon JM et al. 2010 South Korea | 80 adult patients with CO poisoning reviewed retrospectively. Single centre study with data obtained from December 2005-May 2010. Venous or arterial not defined. | Retrospective cohort study | Altered Mental State on admission | High lactate (>2.1mmol/L) n=38 (67.9%) vs. normal lactate (0.7-2.1 mmol/L) n=10 (41.7%); p=0.028 | Single centre and relatively small sample size. Cyanide co-intoxication could not be excluded. Participants excluded if source could not be identified or if inhaled smoke in a confined space therefore limiting applicability. Delayed neurotoxicity days/weeks after exposure not measured. |
Univariate analysis | Elevated lactate associated with poorer short term outcome (odds ratio=1.347, 95% CI 1.103-1.645; p=0.003) | ||||
Multivariate logistic regression: Medical complications defined as neurological deficit at discharge, respiratory failure, hypotension and myocardial injury. | Lactate (mmol/L) was found to be an independent factor associated with medical complications (odds ratio=1.736, 95% CI 1.406-2.883; p=0.033) | ||||
Inoue S, Saito T, Tsuji T, Tamura K, Ohama S, Morita S et al. 2008 Japan | 3 adult patients with CO poisoning following group suicide attempt. Single centre. Serum lactate measured. | Case report | Raised lactate on admission to ED in all 3 patients. All patients treated with HBO. | Age, time of onset of poisoning and treatment administered were almost identical. Therefore authors concluded that initial blood lactate level might be related to respective outcomes. All patients had initial GCS of 6, received initial 2 hours of HBO and then 2 hours a day for 10 days prior to discharge. Patient 1, initial lactate 75.1mg/dL (4.17mmol/L), remained comatose despite treatment, and died on day 31 due to central diabetes insipidus. Patient 2, initial lactate 41.9mg/dL (2.32mmol/L) was discharged after treatment. Re-presented with delayed encephalopathy on day 45. Patient 3, initial lactate 26.3mg/dL (1.46mmol/L) discharged after treatment with no delayed neuropsychiatric sequelae at 1 year follow up. | Single Centre. Small sample size. Correlation between Lactate and outcomes is speculative. |